SRRK
Scholar Rock Holding Corporation Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Scholar Rock (SRRK) Stock: Buy, Sell, or Hold?
$43.72
-2.88 (-6.18%)
▼
5d:
-3.91%
30d:
+10.4%
90d:
-16.76%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 10, 2026
0d
Protect SRRK Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (46%)
Quality Score
52/100
Position
EXTENDED
30-Day Fair Range
$40.57 – $45.87
Position: EXTENDED
Forward P/E & Valuation
-17.8x
Next 12M consensus est.
Wall Street Target
$70.44
+51.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$42.89 / $52.25
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SRRK shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SRRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SRRK is currently trading at $43.72, which is considered extended relative to its 30-day fair value range of $40.57 to $45.87.
Technical Outlook: Technically, SRRK is in a strong downtrend. The price is currently testing key support at $42.89. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $70.44 (+51.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRRK is in a strong downtrend. The price is currently testing key support at $42.89. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $70.44 (+51.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.57 -
$45.87
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
Trading Range & Key Levels
30-Day Trading Range
$40.57 -
$45.87
Current vs Trading Range
EXTENDED
Support Level
$42.89
Resistance Level
$52.25
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding SRRK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 51.2% below Wall St target ($70.44)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-17.75
Wall Street Target
$70.44
(+51.2%)
Revenue Growth (YoY)
-100.0%
Share SRRK Analysis
Share this live SRRK analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SRRK)
Bearish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $SRRK, with traders sharing testimonials, professional overviews, and patient approval stories for the drug Ismestyl. No recent news articles were found.
Key Retail Themes:
Positive testimonials and experiences with Ismestyl
Anticipation for the drug's potential approval and commercial success
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:51 PM ET
Data refreshes hourly during market hours. Next update: 2:51 PM
Data refreshes hourly during market hours. Next update: 2:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRRK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Advanced SRRK Option Strategies
Professional options setups generated by AI based on today's SRRK price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SRRK Research Pages
